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Aim To present and evaluate a new screening protocol for 
amblyopia in preschool children.
Methods Zagreb Amblyopia Preschool Screening (ZAPS) 
study protocol performed screening for amblyopia by 
near and distance visual acuity (VA) testing of 15 648 chil-
dren aged 48-54 months attending kindergartens in the 
City of Zagreb County between September 2011 and 
June 2014 using Lea Symbols in lines test. If VA in either 
eye was >0.1 logMAR, the child was re-tested, if failed at 
re-test, the child was referred to comprehensive eye ex-
amination at the Eye Clinic.
Results 78.04% of children passed the screening test. Es-
timated prevalence of amblyopia was 8.08%. Testability, 
sensitivity, and specificity of the ZAPS study protocol were 
99.19%, 100.00%, and 96.68% respectively.
Conclusion The ZAPS study used the most discriminative 
VA test with optotypes in lines as they do not underesti-
mate amblyopia. The estimated prevalence of amblyopia 
was considerably higher than reported elsewhere. To the 
best of our knowledge, the ZAPS study protocol reached 
the highest sensitivity and specificity when evaluating di-
agnostic accuracy of VA tests for screening. The pass level 
defined at ≤0.1 logMAR for 4-year-old children, using Lea 
Symbols in lines missed no amblyopia cases, advocating 
that both near and distance VA testing should be per-
formed when screening for amblyopia.
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Vision disorders in children represent important public 
health concern as they are acknowledged to be the lead-
ing cause of handicapping conditions in childhood (1). 
Amblyopia, a loss of visual acuity (VA) in one or both eyes 
(2) not immediately restored by refractive correction (3), 
is the most prevalent vision disorder in preschool popu-
lation (4). The estimated prevalence of amblyopia among 
preschool children varies from 0.3% (4) to 5% (5). In addi-
tion, consequences of amblyopia include reduced contrast 
sensitivity and/or positional disorder (6). It develops due 
to abnormal binocular interaction and foveal pattern vi-
sion deprivation or a combination of both factors during a 
sensitive period of visual cortex development (7). Travers-
ing through adulthood, it stands for the leading cause of 
monocular blindness in the 20-70 year age group (8). The 
main characteristic of amblyopia is crowding or spatial in-
terference, referring to better VA when single optotypes 
are used compared to a line of optotypes, where objects 
surrounding the target object deliver a jumbled percept 
(9-12). Acuity is limited by letter size, crowding is limited by 
spacing, not size (12).
Since amblyopia is predominantly defined as subnormal 
VA, a reliable instrument for detecting amblyopia is VA test-
ing (13-15). Moreover, VA testing detects 97% of all ocu-
lar anomalies (13). The gold standard for diagnosing am-
blyopia is complete ophthalmological examination (4). 
There is a large body of evidence supporting the rationale 
for screening, as early treatment of amblyopia during the 
child’s first 5-7 years of life (8) is highly effective in habilita-
tion of VA, while the treatment itself is among the most 
cost-effective interventions in ophthalmology (16). Pre-
school vision screening meets all the World Health Or-
ganization’s criteria for evaluation of screening programs 
(17). Literature search identified no studies reporting un-
healthy and damaging effects of screening. The gold stan-
dard for screening for amblyopia has not been established 
(4). There is a large variety of screening methodologies and 
inconsistent protocols for referral of positives to complete 
ophthalmological examination. Lack of information on the 
validity (18,19) and accuracy (4) of such protocols probably 
intensifies the debate on determining the most effective 
method of vision screening (8,20-29). The unique defini-
tion of amblyopia accepted for research has not reached a 
consensus (4,5,30,31), further challenging the standardiza-
tion of the screening protocols.
Overall, two groups of screening methods exist: the tradi-
tional approach determines VA using VA tests, while the 
alternative approach identifies amblyogenic factors 
(27) based on photoscreening or automated refraction. The 
major difference between the two is that VA-based testing 
detects amblyopia directly, providing an explicit measure 
of visual function, while the latter, seeking for and deter-
mining only the level of refractive status does not evaluate 
visual function. In addition, the diagnosis and treatment 
of amblyopia is governed by the level of VA. On the other 
hand, amblyogenic factors represent risk factors for ambly-
opia to evolve. There are two major pitfalls in screening for 
amblyogenic factors. First, there is a lack of uniform cut-off 
values for referral and second, not all amblyogenic factors 
progress to amblyopia (19).
Besides the issue of what should be detected, amblyopia or 
amblyogenic factors, a question is raised about who should 
be screened. Among literate children, both 3- and 4- year-
old children can be reliably examined. However, 3-year-old 
children achieved testability rate of about 80% and positive 
predictive rate of 58% compared to >90% and 75%, respec-
tively in the 4-year-old group (32). In addition, over-referrals 
are more common among 3-year-old children (32). These 
data determine the age of 4 years as the optimum age to 
screen for amblyopia. Hence, testability is a relevant con-
tributor in designating the optimal screening test.
If VA is to be tested in children, accepted standard tests 
should be used, with well-defined age-specific VA threshold 
determining normal monocular VA. For VA testing of pre-
school children Lea Symbols (33) and HOTV charts (22,32) 
are acknowledged as the best practice (34), while tumbling 
E (28,35,36) and Landolt C (28,37-39) are not appropriate 
as discernment of right-left laterality is still not a fully es-
tablished skill (34,40). The Allen picture test is not standard-
ized (34,41). Both Lea Symbols and HOTV optotypes can 
be presented as single optotypes, single optotypes sur-
rounded with four flanking bars, single line of optotypes 
surrounded with rectangular crowding bars, or in lines of 
optotypes (22,33,34,41-53). The more the noise, the big-
ger the “crowding” effect. Isolated single optotypes without 
crowding overestimate VA (24), hence they are not used in 
clinical practice in Sweden (32). If presented in lines, which 
is recognized as the best composition to detect crowding, 
test charts can be assembled on Snellen or gold standard 
logMAR principle (34,42,51,54). Age-specific thresholds de-
fining abnormal VA in preschool screening for amblyopia 
changed over time from <0.8 to <0.65 for four-year-old chil-
dren due to overload of false positives (20).
The outline of an effective screening test is conclusively 
demonstrated by both high sensitivity and high specificity. 
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Vision screening tests predominately demonstrated higher 
specificity (4). Moreover, sensitivity evidently increased with 
age, whereas specificity remained evenly high (4). The cri-
teria where to set the cut-off point if the confirmatory, di-
agnostic test is expensive or invasive, advocate to minimize 
false positives or use a cut-off point with high specificity.
On the contrary, if the penalty for missing a case is high 
and treatment exists, the test should maximize true posi-
tives and use a cut-off point with high sensitivity (55). A 
screening test for amblyopia should target high sensitivity 
to identify children with visual impairment, while the spec-
ificity should be high enough not to put immense load on 
pediatric ophthalmologists (14). Complete ophthalmologi-
cal examination as the diagnostic confirmatory gold stan-
dard test for amblyopia is neither invasive nor elaborate 
technology is needed, while the penalty for missing a case 
is a lifetime disability.
In devising the Zagreb Amblyopia Preschool Screening 
(ZAPS) study protocol, we decided to use Lea Symbols 
in lines test and to screen preschool children aged 48-54 
months to address the problems declared. Near VA test-
ing was introduced in addition to commonly accepted 
distance VA testing (14,22,24,32,45,56-69) due to several 
reasons: first, hypermetropia is the most common refrac-
tive error in preschool children (70), hence near VA should 
more reliably detect the presence of hypermetropia; sec-
ond, the larger the distance, the shorter the attention span 
is; and third, to increase the accuracy of the test.
The pass cut-off level of ≤0.1 logMAR was defined because 
of particular arguments. Prior to 1992 Sweden used the 
pass cut-off level for screening of 0.8 (20). A change in the 
referral criteria to <0.65 for four-year-old children ensued, 
as many children referred did not require treatment (20). 
In addition, amblyopia treatment outcome of achieved 
VA>0.7 is considered as habilitation of normal vision (3,14). 
At last, the pass cut-off value ≤0.1 logMAR at four years can 
hardly mask serious visual problems, and even if they are 
present, we presume they are mild and can be success-
fully treated at six years when school-entry vision screen-
ing is performed. The aim of the ZAPS study is to present 
and evaluate new screening protocol for preschool chil-
dren aged 48-54 months, established for testing near and 
distance VA using Lea Symbols in lines test. Furthermore, 
we aimed to determine the threshold of age-specific and 
chart-specific VA normative, testability of the ZAPS study 
protocol, and the prevalence of amblyopia in the City of 
Zagreb County. By delivering new evidence on amblyopia 
screening, guideline criteria defining optimal screening 
test for amblyopia in preschool children can be revised in 
favor of better visual impairment clarification.
METhoDS
The ZAPS study protocol and informed consent were con-
firmed by the Institutional Ethics Review Board of the Uni-
versity Hospital “Sveti Duh,” Zagreb. All study procedures 
adhered to the institutional and governmental legislations 
regarding ethical principles for medical research involving 
human subjects, and the tenets of the Declaration of Helsin-
ki. A parent or guardian (hereinafter referred to as “parent“) of 
each study participant gave written informed consent.
Study population
The sample size of this cross-sectional, population-based 
study, consisted of 16 896 eligible children aged 48-54 
months attending kindergartens in the City of Zagreb 
County, in the period September 2011 – June 2014. Paren-
tal consent was obtained for 15 648 (92.61%) children, 998 
(5.91%) parents did not respond, while 250 (1.48%) parents 
rejected for their child to participate. Testing was attempt-
ed in kindergartens, on all 15 648 children, regardless of any 
known developmental or visual disability. Children who 
wore eyeglasses were tested with their eyeglasses (37).
All screeners (N = 17) were attentively and thoroughly 
trained prior to testing and data collection. Care was taken 
about equal distribution of probands per screener.
Study design
The ZAPS study was designed to be performed in four 
phases. LEA SYMBOLS® in lines Pediatric Eye Near and Dis-
tance Charts (Good Lite, Elgin, USA), presenting optotypes 
in the ETDRS format (51) using logMAR progression to de-
tect crowding, were used to test near (40 cm) and distance 
(3 m) VA. Phase I, II, and III were carried out in the kinder-
gartens of The City of Zagreb County by general ophthal-
mologists and residents in ophthalmology. Phase IV was 
conducted at the University Eye Clinic, University Hospital 
“Sveti Duh“ in Zagreb by pediatric ophthalmologists.
Phase I included binocular pre-testing to assess whether 
the child is cognizant with the picture optotypes. In Phase 
II monocular vision testing was conducted, and if the VA 
in either eye was >0.1 logMAR, the child was re-tested 
in Phase III ZAPS study protocol. If failed at re-test, 
CLINICAL SCIENCE32 Croat Med J. 2016;57:29-41
www.cmj.hr
the child was referred to the Eye Clinic for comprehensive 
eye examination to be performed as the gold standard 
procedure for diagnosing amblyopia.
Each parent of the eligible child received an in-home brief 
medical history inquiry including the informed consent 
form. The inquiry incorporated a brochure with general in-
formation on amblyopia, emphasizing the significance of 
screening along with the subjective, parental-reporting as-
sessment of child’s ocular risk factors, general health, and 
environment-related status. As soon as inquiries were col-
lected, VA assessment was carried out.
Phase I. Binocular pre-testing was performed using Lea Sym-
bols in lines distance chart at 0.5 m with 30 M letter line to 
assess whether the child is cognizant with the picture op-
totypes. Monocular vision testing ensued when the child 
identified all four optotypes accurately. If the child did not 
respond at all, the child was labeled as non-cooperative.
Phase II. Monocular vision testing was conducted with the 
right eye approached first, proceeded to the left, with the 
non-testing eye occluded with an adhesive patch. The ex-
amination was performed at near (40 cm), followed by dis-
tance (3 m) VA measurement. Beginning with the 30 M line, 
the examiner continued through descending lines request-
ing the child to read a single optotype per line until replied 
falsely. When incorrect, the examiner presented optotypes 
two lines above the line failed and asked the child to read 
the whole line. Four out of five optotypes in a line accurate-
ly interpreted constituted the pass criterion for the line. The 
pass criterion for the first line 30 M was three out of four op-
totypes. The VA score, measured in logMAR was document-
ed. The pass cut-off level was ≤0.1 logMAR, with fewer than 
two lines difference between the eyes. If the VA in either eye 
was >0.1 logMAR, the child was referred to Phase III. A child 
who had incomplete results in either eye was classified as 
non-testable and was proceeded to Phase III. The criteria for 
referral to Phase III regardless of the VA pass were suspected 
strabismus and ocular disease at examiner’s discretion.
Phase III. The protocol for re-testing the children who failed 
the Phase I and II, followed the same testing procedure 
outlined in Phase I and II. The re-testing was performed 1 
month after the initial test (Phase II). If the VA in either eye 
was >0.1 logMAR, the child was referred to the University 
Eye Clinic to Phase IV. The criteria for referral to complete 
ophthalmological examination regardless of the VA pass 
were suspected strabismus and ocular disease, at ex-
aminer’s discretion.
Phase IV. The in-clinic protocol for presenting VA testing 
of referred children followed the Phase I and Phase II test-
ing procedure. If the VA in either eye was >0.1 logMAR or 
that the child was non-testable or non-cooperative, the in-
clinic standardized comprehensive eye examination was 
performed, including the following (27-29,34,37): history 
taking (date of birth, sex, pregnancy, delivery, and neo-
natal history, gestational age and maturity, birth weight, 
disability at birth, congenital anomalies, developmental 
delay, general health, ocular health and vision disability, 
history of trauma, family general and eye history); Brück-
ner test (71-75) and Hirschberg test (72,76); Titmus stereoa-
cuity test (77) (Stereo Fly Test®, STEREO OPTICAL CO., INC. 
Chicago, IL, USA); cover-uncover and alternating cover test 
for ocular alignment assessment; assessment of motility 
(versions, ductions, and saccades); pupil and anterior seg-
ment examination; cycloplegic retinoscopy with refractive 
error determination; indirect ophthalmoscopy for fundus 
examination. The anterior segment was evaluated using a 
slit lamp. Cycloplegic refraction was performed using 1.0% 
tropicamide (Mydriacyl® 1%, ALCON – COUVREUR, Puurs, 
Belgium), at least 15 minutes after instilling the third of 
three drops, administered in 15-minute intervals. Distance 
VA was re-tested on the same day with a trial lens specta-
cle wearing full cycloplegic correction consistent with pre-
senting VA testing protocol (78).
Definition of amblyopia, refractive error, and testability
The Eye Clinic Expert Panel of Investigators established the 
criteria for amblyopia, refractive error, and testability derived 
from consensus, reviews, and evaluation of existing evi-
dence from major vision screening studies (22,27,30,79,80). 
The criterion for unilateral amblyopia held to ≥2 lines in-
terocular difference (IOD), after re-testing the child on the 
comprehensive eye examination wearing full cycloplegic 
correction, with the best corrected VA of >0.1 logMAR in 
the worse eye presented with amblyogenic factor.
Amblyogenic factors were defined as follows: hyperopia 
≥2.00 D spherical equivalent (SE); myopia ≥3.00 D SE; astig-
matism at any-axis ≥1.00 D; anisometropia ≥1.00 D difference 
in hypermetropia, ≥3.00 D difference in myopia, or ≥1.00 D 
difference in astigmatism in any meridian; antimetropia with 
≥1.00 D SE in the hyperopic eye; strabismus at near and/or 
distance fixation or history of strabismus surgery; history or 
present evidence of the visual axis obstruction.
Bilateral amblyopia held to >0.1 logMAR in both eyes after 
re-testing the child on the comprehensive eye examina-
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tion wearing full cycloplegic correction, in the presence of 
a bilateral amblyogenic factor. Amblyogenic factors were 
defined as bilateral: high hypermetropia ≥4.00 D, myopia 
≥6.00 D, astigmatism ≥2.00 D, or history or present evi-
dence of the visual axis obstruction.
Refractive error held to the best corrected VA≤0.1 logMAR 
after re-testing the child on the comprehensive eye exami-
nation wearing full cycloplegic correction in the presence 
of the amblyogenic factor(s).
Testability was defined for non-testable children. The 
children who gave answers inconclusively or for whom 
the VA measurement could not be completed were ad-
dressed as non-testable (24) and proceeded as failed the 
phase. Testability rate was calculated only after the first 
trial (Phase II).
If the child on the binocular pre-test (Phase I) did not re-
spond at all, the child was labeled as non-cooperative and 
proceeded as failed the phase. Non-cooperative children 
were excluded from the testability analysis as the non-co-
operative child would respond the same regardless of the 
VA test administered.
A child was considered healthy if it had monocular VA≤0.1 
logMAR in both eyes tested at near and distance and unre-
markable ocular status.
outcome measures
The outcome measures of the ZAPS study were:
1) Age specific prevalence rates of amblyopia and refrac-
tive error;
2) Testability of the ZAPS study protocol;
3) Population-based age-specific normative threshold for 
determining abnormal monocular VA in preschool chil-
dren aged 48-54 months using Lea Symbols in lines chart 
in the City of Zagreb County;
4) Sensitivity and specificity of the near/distance vision test 
using Lea Symbols in lines chart for near/distance in the 
City of Zagreb County;
5) Sensitivity and specificity of the ZAPS study protocol us-
ing Lea Symbols in lines chart for near and distance in the 
City of Zagreb County.
Data extraction for the sensitivity and specificity 
analysis
Children referred to the Eye Clinic and diagnosed with am-
blyopia who were labeled as non-cooperative or non-test-
able at the screening test were excluded from the accuracy 
analysis.
Sensitivity and specificity analysis for the near and distance 
vision test separately was performed on the population of 
patients examined at the Eye Clinic.
Sensitivity and specificity analysis for the ZAPS study proto-
col was performed using data from the City of Zagreb reg-
istration system on VA testing performed prior to school 
enrollment at health care centers. The VA testing prior to 
school enrollment is a national health policy conducted by 
occupational health specialists at health care centers using 
age-appropriate vision screening test (tumbling E, Landolt 
C). The screening techniques used by health profession-
als are not unique in terms of vision test used, approach 
to the technique of testing, testing distance, pass criteri-
on for the line, pass cut-off criteria for referral to complete 
ophthalmological examination, or providers’ attentiveness, 
experience, and training. Children who fail the school-en-
try screening are referred to pediatric ophthalmologist for 
comprehensive eye examination.
During the period December 2011-September 2015, the 
total number of N = 9540 ZAPS screened children per-
formed VA testing prior to school enrollment at health 
care centers. Additional feedback was provided after the 
conclusion of the above stated period from the medical 
centers with pediatric ophthalmology departments in the 
City of Zagreb County on the number of children who 
passed the ZAPS study protocol but failed on school-entry 
screening. The number of false negatives was concluded 
to be zero as no new case of amblyopia was confirmed for 
the children who passed the ZAPS protocol but failed on 
school-entry screening either at the Eye Clinic or at medi-
cal centers with pediatric ophthalmology departments in 
the City of Zagreb County.
Data analysis
Data are presented with absolute and relative frequen-
cies including 95% confidence intervals (CI). Percentag-
es with respective 95% confidence intervals (CI) were 
calculated for N = 15 648 subjects in the study, but 
also as expected values if all eligible N = 16 896 sub-
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jects were screened. Data were calculated using MedCalc 
Statistical Software ver. 15.8 (MedCalc Software bvba, Os-
tend, Belgium; http://www.medcalc.org; 2015) including 
calculation of sensitivity, specificity, positive predictive 
value (PPV), and negative predictive value (NPV). Signifi-
cance level was set to 0.05.
RESuLTS
Through September 2011-June 2014, 15 648 children 
were screened, which determined the attendance rate of 
92.61% of the 16 896 children registered in the kindergar-
tens of The City of Zagreb County. Flowchart of longitu-
dinal follow-up of all the probands included in the ZAPS 
study is presented in Figure 1.
Outcome 1. Age-specific prevalence rates of amblyopia 
and refractive error. The ZAPS study found the estimated 
prevalence of amblyopia of 8.08% (Table 1). The estimated 
prevalence of refractive error was 2.37% (Table 1).
Outcome 2. Testability of the ZAPS study protocol. Testability 
rate at the initial examination was 99.19% (Table 1). For 1563 
children the re-examination test (Phase III) was not per-
formed due to parental non-compliance. As this subgroup 
of children failed the initial exam, instructions were given via 
FiguRE 1. Flow-chart of longitudinal follow-up of all the probands included in the study. oE – ophthalmological examination.
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caregivers in the kindergartens for the child to be referred to 
complete the ophthalmological examination in the Clinic.
Out of 3435 referred children, 634 responded to complete 
the ophthalmological examination at the Clinic (Figure 1).
Outcome 3. Population-based age-specific normative 
threshold for determining abnormal monocular visual 
acuity in preschool children aged 48-54 months using 
Lea Symbols in lines chart in the City of Zagreb County. Of 
15 648 children in the ZAPS study cohort, 12 213 children 
(78.04%) passed the screening with the cut-off level ≤0.1 
logMAR in both eyes tested at near and distance.
Outcome 4. Diagnostic accuracy of near/distance vision 
test using Lea Symbols in lines chart for near/distance in 
the City of Zagreb County, if testing near/distance visual 
acuity alone. Children referred to the Eye Clinic and diag-
nosed with amblyopia who were labeled as non-cooper-
ative or non-testable at the screening test (N = 32) were 
excluded from the accuracy analysis. Near vision test 
using Lea Symbols in lines chart for near, if performed 
alone, would have sensitivity of 74.5% and specificity of 
43.5% (Table 2). Sensitivity of the distance vision test us-
ing Lea Symbols in lines chart for distance, if tested alone, 
would reach 96.4%, however specificity would be only 
11.7% (Table 2).
TABLE 1. Characteristics of probands in the prevalence and testability analysis*
Expected values for the eligible population
Proband N /N % 95% Ci N % 95% Ci
Agreed to participate 15 648 16 896 92.61 92.21-92.99 n/a n/a n/a
Parent did not respond 998 16 896 5.91 5.56-6.28 n/a n/a n/a
Refused to participate 250 16 896 1.48 1.31-1.67 n/a n/a n/a
Amblyopia suspect, after P II 5685 15 648 36.33 35.58-37.09 n/a n/a n/a
Amblyopia suspect, after P III 3435 5685 60.42 59.14-61.68 n/a n/a n/a
Referred to OE 3435 15 648 21.95 21.31-22.61 3709 21.95 21.33-22.58
Non-testable after P II 127 15 648 0.81 0.68-0.96  137  0.81 0.69-0.96
Non-testable after P III 33 15 648 0.21 0.15-0.29   36  0.21 0.15-0.29
Responded to referral to OE 634 3435 18.46 17.20-19.79 n/a n/a n/a
Amblyopia confirmed 252 634 39.75 36.01-43.61 1365  8.08 7.68-8.50
RE confirmed 74 634 11.67 9.40-14.40  401  2.37 2.15-2.61
Amblyopia and RE confirmed 326 634 51.42 47.53-55.29 1766 10.45 10.00-10.92
False positive 308 634 48.58 44.71-52.47 1669  9.88 9.44-10.34
*N – nominator; /N – denominator; Ci – confidence interval; n/a not applicable; P – phase; oE – ophthalmological examination; RE – refractive error.
TABLE 2. outcome measures. Diagnostic accuracy of near vision test using LEA SYMBoLS® in lines Pediatric Eye Chart for near in 
the City of Zagreb County, if testing near visual acuity alone (N = 528 children). Diagnostic accuracy of distance vision test using 
LEA SYMBoLS® in lines Pediatric Eye Chart for distance in the City of Zagreb County, if testing distance visual acuity alone (N = 528 
children)
Screening test – near Screening test – distance
Failed Passed Total Failed Passed Total
Amblyopia present 164  56 220* 212  8 220*
Healthy 174 134 308 272 36 308
Total 338 190 528 484 44 528
Sensitivity (95% CI) %  74.5 (68.3-80.2)  96.4 (92.9-98.4)
Specificity (95% CI) %  43.5 (37.9-49.3)  11.7 (8.3-15.8)
PPV† (95% CI) %  11.2 (7.9-15.2)   9.4 (6.9- 12.4)
NPV† (95% CI) %  94.7 (90.9-97.3)  97.1 (88.9-99.7)
*252 subjects were diagnosed with amblyopia, however, 32 children referred to the Eye Clinic and diagnosed with amblyopia were labeled as non-
cooperative or non-testable at the screening test, and were excluded from the diagnostic accuracy analysis of near and distance vision test using 
LEA SYMBoLS® in lines Pediatric Eye Chart.
†Positive and negative predictive values were calculated with amblyopia estimated prevalence 8.1%. Ci – confidence interval; PPV – positive predic-
tive value; NPV – negative predictive value.
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Outcome 5. Diagnostic accuracy of the ZAPS study proto-
col using Lea Symbols in lines chart for near and distance 
in the City of Zagreb County. The analysis was performed 
on N = 9228 probands, as children who were referred to 
the Eye Clinic and diagnosed with amblyopia but labeled 
as non-cooperative or non-testable at the screening test 
(N = 32) were excluded from the accuracy analysis of the 
total number of N = 9540 ZAPS screened children who per-
formed visual acuity testing prior to school enrollment at 
health care centers. The sensitivity and specificity of the 
ZAPS study protocol were 100.00% and 96.68%, respec-
tively (Table 3).
DiSCuSSioN
The ZAPS study is an extensive investigation of amblyo-
pia prevalence based on the unique, highly standardized 
screening protocol distinctive for 1) both near and dis-
tance VA testing, 2) using testing chart with optotypes in 
lines and 3) setting VA of ≤0.1 logMAR as the pass cut-off 
value, administered on a large study-cohort of the 48-54 
month-old children.
Amblyopia and refractive error prevalence
The estimated prevalence of amblyopia among preschool 
children varies from 0.3% (4) to 5% (5). The ZAPS study 
found the estimated prevalence of amblyopia to be 
8.08%, considerably higher than reported elsewhere. 
It is speculated that in developing countries, where 
national screening is not established, higher rates of am-
blyopia are expected (81). A few studies reported the prev-
alence rates of visual impairment ranging from 6.3%-31% 
(45,56,57,60,62). These large discrepancies can be attrib-
uted to a wide variety of screening protocols using differ-
ent screening tests and different designs of the same test, 
inconsistent criteria for defining amblyopia, amblyogenic 
factors, refractive errors, and thresholds of age-specific VA 
normative (4). It is well recognized that optotypes in lines 
assembled on logMAR principle are the best frame for am-
blyopia detection (10,34,53,82).
Another important finding of the ZAPS study is the relative 
preponderance of amblyopia compared to the estimated 
prevalence of refractive error, suggesting that if significant 
refractive error is discovered at the age of 4 years it is likely 
that amblyopia has already been well-established.
Age-specific normative threshold for determining 
abnormal monocular VA
This study revealed that 78.04% of 48-54 month-old chil-
dren reached VA of ≤0.1 logMAR. The Multi-Ethnic Pediatric 
Eye Disease Study (MEPEDS) group proposed the thresh-
old of 20/40 for defining abnormal monocular VA using 
HOTV optotypes in children aged 48-59 months (64). The 
proportion of children achieving the threshold was 99% 
(64). Compared to our study results and earlier reports on 
the prevalence of amblyopia ranging 0.8%-10% (30,83-89), 
we speculate that 20/40 threshold is too low for the 4-year-
old age group as this refers only 1% of children to the com-
plete ophthalmological examination, under-representing 
the number of false negatives who pass the screening but 
do have some kind of visual impairment. Advocating for 
more stringent threshold criteria, Vision in Preschoolers 
(VIP) study group concluded that the threshold levels as-
sociated with an increased risk of amblyopia recommend-
ed by professional organizations might be exceedingly le-
nient (90). Our data are in agreement with the study by 
Leone et al (80), who found the mean VA of 0.26 logMAR 
(6/11) at <36 months, which improved to 0.1 (6/7.5) at 66 
to <72 months using ETDRS HOTV chart.
Testability
We found an excellent testability rate at the initial exami-
nation (99.19%). This is comparable to VIP study results that 
found Lea Symbols highly testable, with the proportion 
of 99.5% testable children (67). However, VIP study used a 
modification of the MassVAT form of the Lea Symbols (91), 
TABLE 3. outcome measures. Diagnostic accuracy of the ZAPS 
study protocol using LEA SYMBoLS® in lines Pediatric Eye 
Chart for near in the City of Zagreb County (N = 9508 children)
Screening test - near and distance
Failed Passed Total
Amblyopia present 220*    0  220*
Healthy 308 8980 9288
Total 528 8980 9508
Sensitivity (95% CI) % 100% (98.34% to 100.00%)
Specificity (95% CI) %  96.68% (96.30% to 97.04%)
PPV†(95% CI) %  72.66% (69.87% to 75.33%)
NPV†(95% CI) % 100% (99.96% to 100.00%)
*252 subjects were diagnosed with amblyopia, however, 32 children 
referred to the Eye Clinic and diagnosed with amblyopia were labeled 
as non-cooperative or non-testable at the screening test, and were 
excluded from the diagnostic accuracy analysis of near and distance 
vision test using LEA SYMBoLS® in lines Pediatric Eye Chart.
†Positive and negative predictive values were calculated with amblyo-
pia estimated prevalence 8.1%. ZAPS – Zagreb Amblyopia Preschool 
Screening; Ci – confidence interval; PPV – positive predictive value; 
NPV – negative predictive value.
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and not the optotypes in lines presented in the gold stan-
dard ETDRS format.
De Becker et al found 95% testability rate using single op-
totypes of Lea Symbols (58). When Amblyopia Treatment 
Study (ATS) HOTV protocol was used, testability reached 
95% for the 48-54 months aged group (80). It is proposed 
that HOTV optotypes arranged linearly may be optimal 
only for children >5 years (80), however, high testability 
rate of the ZAPS study indicates that optotypes in lines are 
applicable for children aged 48-54 months if Lea Symbols 
are used, as they have the contours and meaning that chil-
dren have already been exposed to and are intellectually 
easier to perceive and comprehend.
Diagnostic accuracy
The ZAPS study protocol satisfies the prerequisites of high 
testability, high sensitivity, and high specificity, which 
makes it an efficient screening test. The published studies 
analyzing VA assessment for amblyopia screening in chil-
dren failed to reach both high testability and high specific-
ity and sensitivity in the same test (22).
The sensitivity and specificity of the ZAPS study protocol 
were 100.00% and 96.68% respectively. If each of these 
tests had been performed alone, both sensitivity and spec-
ificity would have declined. The former Swedish screen-
ing program testing distance VA with HVOT in lines op-
totypes and the pass level of ≥0.8 for 4-year-old children 
obtained sensitivity of 86% and specificity of 97% (14). The 
limit of <0.65 was associated with sensitivity decrease to 
70.4% (14). In the study by Bertuzzi et al, VA score set at 
0.63 resulted in sensitivity of 78% and specificity of 93% 
(45). When the cut-off level was raised to 0.8, sensitivity 
was 96% and specificity 83% (45). Lowering the limit for 
referral predisposes to a higher number of false negatives. 
The VIP Study Group set the specificity at 90%, with failure 
criterion of inability to pass 0.5 line in 4-year-old children 
and achieved the sensitivity of Lea Symbol test of only 61% 
(67). When sensitivity was set to 95%, specificity declined 
to 38%. Overall, the sensitivity of VA tests ranged between 
9% (45,60) and 100% (68), and the specificity between 8% 
(45) and 100% (45,60), however the studies reporting diag-
nostic accuracy of the screening test used VA testing either 
for distance or near.
The ZAPS study strengths include a highly standardized 
study design using optotypes in lines presented in the gold 
standard ETDRS format as they do not underestimate am-
blyopia, and population-based results obtained on a large 
sample size. All screeners were either residents in ophthal-
mology or ophthalmology specialists. However, the exam-
iner’s discretion could be a possible source of bias because 
their decision for referral was based on the inspection as 
no further testing was allowed during the screening proc-
ess. The study limitation could be found in testing the VA 
twice, first at near followed by distance VA measurement. 
The larger number of over-referrals due to distance VA test-
ing could be the result of fatigue and limited attention 
span, as distance acuity measurement followed near acu-
ity testing, and a question is raised if randomization would 
have reversed the difference. Second, the children who 
passed the screening were not investigated further with 
comprehensive eye examination. Hence, we determined 
the false-negative rate based on the vision screening at 
school entry, as reported in Methods. Another limitation of 
the study was a large loss of probands, thus, we could not 
calculate the prevalence of the sample, but had to present 
the estimated prevalence, this being the standard proce-
dure in such cases (92,93).
In conclusion, ZAPS study yielded high estimated preva-
lence rate of amblyopia of 8.1%. To the best of our knowl-
edge, its protocol reached the highest sensitivity and spe-
cificity when evaluating diagnostic accuracy of VA tests for 
screening preschool children aged 48-54 months. Sensitiv-
ity of 100% and specificity of 96% advocate that both near 
and distance VA testing using Lea Symbols in lines chart 
should be performed in a single session when screening 
for amblyopia. The chart- and age-specific threshold de-
termining abnormal monocular VA is redefined, and raised 
to >0.1 logMAR.
The ZAPS study changed the national recommendations 
for health surveillance in Croatia in favor of VA assessment 
of 4-year-old children. From June 1st 2015, vision screen-
ing of all 4-year-old children performed in ophthalmolo-
gists’ practices is introduced as a national health policy. We 
recommend further systematic examination of the ZAPS 
study protocol in a longitudinal study design.
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